Related Experiment Video
Updated: Aug 14, 2026
10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Thrombophilia: implications for pregnancy outcome
1Department of Obstetrics and Gynaecology, Glasgow Royal Infirmary, University of Glasgow, 10 Alexandra Parade, Glasgow G31 2ER, Scotland, UK. I.A.Greer@clinmed.gla.ac.uk
Thrombosis Research
|April 23, 2003
Summary
Thrombophilias, or blood clotting disorders, are linked to pregnancy complications like miscarriage and pre-eclampsia. Early detection may help manage risks and prevent adverse outcomes.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Reproductive Medicine
Background:
- Pregnancy is a natural hypercoagulable state, increasing risks when combined with thrombophilias.
- Congenital and acquired thrombophilias are increasingly implicated in adverse pregnancy outcomes.
- Conditions like antiphospholipid antibody syndrome are known risks for recurrent fetal loss.
Purpose of the Study:
- To review the evidence linking thrombophilias to miscarriage, intrauterine growth restriction (IUGR), and pre-eclampsia.
- To explore the potential role of thrombophilia in the severity of pregnancy complications.
- To discuss screening implications and potential therapeutic strategies.
Main Methods:
- Literature review of studies on thrombophilia and adverse pregnancy outcomes.
- Analysis of associations between inherited/acquired thrombophilias and conditions like pre-eclampsia and IUGR.
- Examination of treatment efficacy for antiphospholipid antibody syndrome.
Main Results:
- Thrombophilias are associated with miscarriage, IUGR, and pre-eclampsia, though links with hereditary forms are inconsistent.
- Antiphospholipid antibody syndrome increases fetal loss risk, manageable with heparin and aspirin.
- Thrombophilia may influence pregnancy complication severity rather than directly cause them.
Conclusions:
- Thrombophilia screening in patients with recurrent miscarriage, IUGR, or pre-eclampsia may indicate a higher risk of venous thromboembolism (VTE).
- Further research is needed to clarify the benefits of managing other thrombophilic conditions beyond antiphospholipid antibody syndrome.
- Understanding thrombophilia's role is crucial for managing complex pregnancy complications.
More Related Videos
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
08:50Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...